The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Microbial Alternative Protein Market Research Report 2024

Global Microbial Alternative Protein Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1608705

No of Pages : 78

Synopsis
Microbial alternative protein refers to the use of microorganisms (usually proteins produced by microbial fermentation) as food ingredients that replace traditional animal and plant proteins. This method typically involves placing microorganisms, such as bacteria, yeast, or fungi, in a specific culture medium to produce proteins through a fermentation process.
The global Microbial Alternative Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Microbial Alternative Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microbial Alternative Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Microbial Alternative Protein include AgriProtein (South Africa), Ynsect (France), Enterra Feed Corporation (Canada), Protix (The Netherlands), Proti-Farm Holding NV (The Netherlands), Entomo Farms (Canada), Global Bugs Asia Co., Ltd. (Thailand), Aspire Food Group (U.S.) and Tiny Farms (U.S.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microbial Alternative Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Alternative Protein.
Report Scope
The Microbial Alternative Protein market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbial Alternative Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbial Alternative Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AgriProtein (South Africa)
Ynsect (France)
Enterra Feed Corporation (Canada)
Protix (The Netherlands)
Proti-Farm Holding NV (The Netherlands)
Entomo Farms (Canada)
Global Bugs Asia Co., Ltd. (Thailand)
Aspire Food Group (U.S.)
Tiny Farms (U.S.)
Segment by Type
Yeast Protein
Microalgae Protein
Bacterial Protein
Other
Segment by Application
Food
Feed
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microbial Alternative Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microbial Alternative Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Microbial Alternative Protein Market Overview
1.1 Product Overview and Scope of Microbial Alternative Protein
1.2 Microbial Alternative Protein Segment by Type
1.2.1 Global Microbial Alternative Protein Market Value Comparison by Type (2024-2030)
1.2.2 Yeast Protein
1.2.3 Microalgae Protein
1.2.4 Bacterial Protein
1.2.5 Other
1.3 Microbial Alternative Protein Segment by Application
1.3.1 Global Microbial Alternative Protein Market Value by Application: (2024-2030)
1.3.2 Food
1.3.3 Feed
1.3.4 Others
1.4 Global Microbial Alternative Protein Market Size Estimates and Forecasts
1.4.1 Global Microbial Alternative Protein Revenue 2019-2030
1.4.2 Global Microbial Alternative Protein Sales 2019-2030
1.4.3 Global Microbial Alternative Protein Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Microbial Alternative Protein Market Competition by Manufacturers
2.1 Global Microbial Alternative Protein Sales Market Share by Manufacturers (2019-2024)
2.2 Global Microbial Alternative Protein Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Microbial Alternative Protein Average Price by Manufacturers (2019-2024)
2.4 Global Microbial Alternative Protein Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microbial Alternative Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microbial Alternative Protein, Product Type & Application
2.7 Microbial Alternative Protein Market Competitive Situation and Trends
2.7.1 Microbial Alternative Protein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microbial Alternative Protein Players Market Share by Revenue
2.7.3 Global Microbial Alternative Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microbial Alternative Protein Retrospective Market Scenario by Region
3.1 Global Microbial Alternative Protein Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Microbial Alternative Protein Global Microbial Alternative Protein Sales by Region: 2019-2030
3.2.1 Global Microbial Alternative Protein Sales by Region: 2019-2024
3.2.2 Global Microbial Alternative Protein Sales by Region: 2025-2030
3.3 Global Microbial Alternative Protein Global Microbial Alternative Protein Revenue by Region: 2019-2030
3.3.1 Global Microbial Alternative Protein Revenue by Region: 2019-2024
3.3.2 Global Microbial Alternative Protein Revenue by Region: 2025-2030
3.4 North America Microbial Alternative Protein Market Facts & Figures by Country
3.4.1 North America Microbial Alternative Protein Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Microbial Alternative Protein Sales by Country (2019-2030)
3.4.3 North America Microbial Alternative Protein Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microbial Alternative Protein Market Facts & Figures by Country
3.5.1 Europe Microbial Alternative Protein Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Microbial Alternative Protein Sales by Country (2019-2030)
3.5.3 Europe Microbial Alternative Protein Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microbial Alternative Protein Market Facts & Figures by Country
3.6.1 Asia Pacific Microbial Alternative Protein Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Microbial Alternative Protein Sales by Country (2019-2030)
3.6.3 Asia Pacific Microbial Alternative Protein Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microbial Alternative Protein Market Facts & Figures by Country
3.7.1 Latin America Microbial Alternative Protein Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Microbial Alternative Protein Sales by Country (2019-2030)
3.7.3 Latin America Microbial Alternative Protein Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microbial Alternative Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Microbial Alternative Protein Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Microbial Alternative Protein Sales by Country (2019-2030)
3.8.3 Middle East and Africa Microbial Alternative Protein Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microbial Alternative Protein Sales by Type (2019-2030)
4.1.1 Global Microbial Alternative Protein Sales by Type (2019-2024)
4.1.2 Global Microbial Alternative Protein Sales by Type (2025-2030)
4.1.3 Global Microbial Alternative Protein Sales Market Share by Type (2019-2030)
4.2 Global Microbial Alternative Protein Revenue by Type (2019-2030)
4.2.1 Global Microbial Alternative Protein Revenue by Type (2019-2024)
4.2.2 Global Microbial Alternative Protein Revenue by Type (2025-2030)
4.2.3 Global Microbial Alternative Protein Revenue Market Share by Type (2019-2030)
4.3 Global Microbial Alternative Protein Price by Type (2019-2030)
5 Segment by Application
5.1 Global Microbial Alternative Protein Sales by Application (2019-2030)
5.1.1 Global Microbial Alternative Protein Sales by Application (2019-2024)
5.1.2 Global Microbial Alternative Protein Sales by Application (2025-2030)
5.1.3 Global Microbial Alternative Protein Sales Market Share by Application (2019-2030)
5.2 Global Microbial Alternative Protein Revenue by Application (2019-2030)
5.2.1 Global Microbial Alternative Protein Revenue by Application (2019-2024)
5.2.2 Global Microbial Alternative Protein Revenue by Application (2025-2030)
5.2.3 Global Microbial Alternative Protein Revenue Market Share by Application (2019-2030)
5.3 Global Microbial Alternative Protein Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AgriProtein (South Africa)
6.1.1 AgriProtein (South Africa) Corporation Information
6.1.2 AgriProtein (South Africa) Description and Business Overview
6.1.3 AgriProtein (South Africa) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AgriProtein (South Africa) Microbial Alternative Protein Product Portfolio
6.1.5 AgriProtein (South Africa) Recent Developments/Updates
6.2 Ynsect (France)
6.2.1 Ynsect (France) Corporation Information
6.2.2 Ynsect (France) Description and Business Overview
6.2.3 Ynsect (France) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ynsect (France) Microbial Alternative Protein Product Portfolio
6.2.5 Ynsect (France) Recent Developments/Updates
6.3 Enterra Feed Corporation (Canada)
6.3.1 Enterra Feed Corporation (Canada) Corporation Information
6.3.2 Enterra Feed Corporation (Canada) Description and Business Overview
6.3.3 Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Portfolio
6.3.5 Enterra Feed Corporation (Canada) Recent Developments/Updates
6.4 Protix (The Netherlands)
6.4.1 Protix (The Netherlands) Corporation Information
6.4.2 Protix (The Netherlands) Description and Business Overview
6.4.3 Protix (The Netherlands) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Protix (The Netherlands) Microbial Alternative Protein Product Portfolio
6.4.5 Protix (The Netherlands) Recent Developments/Updates
6.5 Proti-Farm Holding NV (The Netherlands)
6.5.1 Proti-Farm Holding NV (The Netherlands) Corporation Information
6.5.2 Proti-Farm Holding NV (The Netherlands) Description and Business Overview
6.5.3 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Portfolio
6.5.5 Proti-Farm Holding NV (The Netherlands) Recent Developments/Updates
6.6 Entomo Farms (Canada)
6.6.1 Entomo Farms (Canada) Corporation Information
6.6.2 Entomo Farms (Canada) Description and Business Overview
6.6.3 Entomo Farms (Canada) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Entomo Farms (Canada) Microbial Alternative Protein Product Portfolio
6.6.5 Entomo Farms (Canada) Recent Developments/Updates
6.7 Global Bugs Asia Co., Ltd. (Thailand)
6.6.1 Global Bugs Asia Co., Ltd. (Thailand) Corporation Information
6.6.2 Global Bugs Asia Co., Ltd. (Thailand) Description and Business Overview
6.6.3 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Portfolio
6.7.5 Global Bugs Asia Co., Ltd. (Thailand) Recent Developments/Updates
6.8 Aspire Food Group (U.S.)
6.8.1 Aspire Food Group (U.S.) Corporation Information
6.8.2 Aspire Food Group (U.S.) Description and Business Overview
6.8.3 Aspire Food Group (U.S.) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aspire Food Group (U.S.) Microbial Alternative Protein Product Portfolio
6.8.5 Aspire Food Group (U.S.) Recent Developments/Updates
6.9 Tiny Farms (U.S.)
6.9.1 Tiny Farms (U.S.) Corporation Information
6.9.2 Tiny Farms (U.S.) Description and Business Overview
6.9.3 Tiny Farms (U.S.) Microbial Alternative Protein Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tiny Farms (U.S.) Microbial Alternative Protein Product Portfolio
6.9.5 Tiny Farms (U.S.) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microbial Alternative Protein Industry Chain Analysis
7.2 Microbial Alternative Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microbial Alternative Protein Production Mode & Process
7.4 Microbial Alternative Protein Sales and Marketing
7.4.1 Microbial Alternative Protein Sales Channels
7.4.2 Microbial Alternative Protein Distributors
7.5 Microbial Alternative Protein Customers
8 Microbial Alternative Protein Market Dynamics
8.1 Microbial Alternative Protein Industry Trends
8.2 Microbial Alternative Protein Market Drivers
8.3 Microbial Alternative Protein Market Challenges
8.4 Microbial Alternative Protein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’